Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/26/2010CA2753195A1 Iminosugars and methods of treating viral diseases
08/26/2010CA2753169A1 Nucleic acids specifically binding with human factor vii/viia and uses thereof
08/26/2010CA2753106A1 Hydrogel contact lens for sustained drug release and drug release method using hydrogel contact lens for sustained drug release
08/26/2010CA2753048A1 Streptavidin having low immunogenicity and use thereof
08/26/2010CA2753034A1 Methods of and compositions for reducing cell death
08/26/2010CA2753010A1 Pyridocarbazole type compounds and applications thereof
08/26/2010CA2752961A1 Glycolipid mixture with antiinflammatory acivity obtained from oscillatoria planktothrix
08/26/2010CA2752807A1 Amine or amino alcohols as glyt1 inhibitors
08/26/2010CA2752805A1 Formulation comprising drospirenone for subcutaneous or intramuscular administration
08/26/2010CA2752796A1 Cyclopropyl amide derivatives targeting the histamine h3 receptor
08/26/2010CA2752739A1 1,4-benzodiazepin-2-on derivatives
08/26/2010CA2752720A1 Hydrogel of polysaccharide derivative
08/26/2010CA2752693A1 Triazolopyridine derivatives as p38 map kinase inhibitors
08/26/2010CA2752674A1 Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
08/26/2010CA2752603A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
08/26/2010CA2752596A1 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
08/26/2010CA2752579A1 Hepatitis c virus inhibitors
08/26/2010CA2752560A1 Foxm1 peptides and vaccines containing the same
08/26/2010CA2752527A1 Indole/benzimidazole compounds as mtor kinase inhibitors
08/26/2010CA2752319A1 Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd
08/26/2010CA2752265A1 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases
08/26/2010CA2752212A1 4-isopropylphenyl glucitol compounds as sgltl inhibitors
08/26/2010CA2751777A1 Novel ortho-aminoamides for the treatment of cancer
08/26/2010CA2751767A1 3,3'-spiroindolinone derivatives as anticancer agents
08/26/2010CA2751244A1 Pyrimidin-4(3h)-one derivatives
08/26/2010CA2750993A1 Carboxamide compounds and their use as calpain inhibitors
08/26/2010CA2750985A1 Methods and compositions for diagnosis and treatment of cancer
08/26/2010CA2750708A1 Pyrazolo [4,3-c] cinnolin-3-one m1 receptor positive allosteric modulators
08/26/2010CA2750635A1 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/26/2010CA2750564A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/26/2010CA2749867A1 Heteroaryl substituted pyridazinone derivatives
08/26/2010CA2749649A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
08/26/2010CA2749495A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/26/2010CA2749059A1 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) -8-hydroxyquinolin-2 (1h)-one for the treatment of lung function
08/26/2010CA2749045A1 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquin olin-2(1h)-one and its use in the treatment of pulmonary diseases
08/26/2010CA2748701A1 Pyrrolidine derivatives as nk3 receptor antagonists
08/26/2010CA2747395A1 Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
08/26/2010CA2741984A1 Novel and potent tapentadol dosage forms
08/26/2010CA2739571A1 Amino acid salts of prostaglandins
08/25/2010EP2221377A1 Oligonucleotide compositions with enhanced efficiency
08/25/2010EP2221375A1 Methods and compositions for diagnosis and treatment of cancer
08/25/2010EP2221368A1 West nile virus vaccine, and method for production thereof
08/25/2010EP2221309A1 Novel naphthyridine derivative monohydrate and method for producing the same
08/25/2010EP2221308A1 Benzazepinone compound
08/25/2010EP2221307A1 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
08/25/2010EP2221301A1 Heteroaryloxy quinazoline derivative
08/25/2010EP2221298A1 Phenylpyrazole derivatives
08/25/2010EP2221297A1 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
08/25/2010EP2221296A1 Fused indane compound
08/25/2010EP2221291A1 Cyclohexenone compounds from antrodia camphorata and pharmaceutical compositions thereof useful for treating autoimmune diseases
08/25/2010EP2221089A1 Lipoxin analogs as novel inhibitors of angiogenesis
08/25/2010EP2221059A1 Composition for reducing the level of glucose, malondialdehyde-modified ldl, homocysteine and/or c-reactive protein in blood
08/25/2010EP2221058A1 Antimelancholic medicine prepared with jujube camp materials
08/25/2010EP2221057A1 Sense-improving agent
08/25/2010EP2221056A1 Tetracyclines for the treatment of acne
08/25/2010EP2221055A1 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
08/25/2010EP2221054A1 CDK inhibitors for lowering intraocular pressure
08/25/2010EP2221053A1 Pharmaceutical composition comprising protein methyltransferase I inhibitors and its use for treating tumour diseases
08/25/2010EP2221052A2 Compositions that treat or inhibit pathological conditions associated with inflammatory response
08/25/2010EP2221051A1 Amine derivative having npy y5 receptor antagonist activity and use thereof
08/25/2010EP2221049A2 Solid pharmaceutical composition of ded anosine
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2221040A1 Composition for external application to skin
08/25/2010EP2220208A2 Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease
08/25/2010EP2220104A1 Process for the production of telithromycin
08/25/2010EP2220103A1 Novel mangiferin calcium salts, the method for its preparation and its use
08/25/2010EP2220097A1 Beta-lactamase inhibitors
08/25/2010EP2220096A1 Beta-lactamase inhibitors
08/25/2010EP2220095A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220092A1 Azaindolizines and methods of use
08/25/2010EP2220091A2 Reverse transcriptase inhibitors
08/25/2010EP2220088A2 New smac mimetic compounds as apoptosis inducers
08/25/2010EP2220085A1 Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes
08/25/2010EP2220084A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220083A2 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
08/25/2010EP2220082A2 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
08/25/2010EP2220080A2 Heterocyclic derivatives as modulators of ion channels
08/25/2010EP2220079A2 Substituted amides, manufacturing and use thereof as medicaments
08/25/2010EP2220078A2 Benzomorpholine derivatives and methods of use
08/25/2010EP2220077A1 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases
08/25/2010EP2220076A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220074A1 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
08/25/2010EP2220073A1 Pyridazinone derivatives as parp inhibitors
08/25/2010EP2220072A2 Polymorphs of sunitinib base and processes for preparation thereof
08/25/2010EP2220071A2 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
08/25/2010EP2220070A1 2-benzylpyridazinone derivatives as met kinase inhibitors
08/25/2010EP2220069A1 Methods for identification of jak kinase interacting molecules and for the purification of jak kinases
08/25/2010EP2220068A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
08/25/2010EP2220066A1 Benzofuran anilide histone deacetylase inhibitors
08/25/2010EP2220065A2 Modulators of ccr9 receptor and methods of use thereof
08/25/2010EP2220062A1 New human papilloma virus inhibitors and pharmaceutical compositions containing same
08/25/2010EP2220061A1 Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting ksp kinesin activity
08/25/2010EP2220060A1 Medicaments
08/25/2010EP2220059A1 2-aminooxazole derivatives as trpvl antagonists useful for treating pain
08/25/2010EP2220057A2 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions
08/25/2010EP2220055A2 Novel heterocyclyl compounds and their use as chemokine antagonists
08/25/2010EP2220054A2 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
08/25/2010EP2220053A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists
08/25/2010EP2220052A1 Cyclic urea inhibitors of 11 -hydroxysteroid dehydrogenase 1
08/25/2010EP2220051A1 Pyridazine derivatives useful as fungicides and for the treatment of cancer
1 ... 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 ... 7860